Page 6 - ஜீன் கிளாட் தாற்டிப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜீன் கிளாட் தாற்டிப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜீன் கிளாட் தாற்டிப் Today - Breaking & Trending Today

Health Canada might approve arthritis medicine to treat COVID


iPolitics
By Charlie Pinkerton. Published on Jan 27, 2021 4:31pm
Health Canada s Ottawa offices (Jolson Lim/iPolitics)
If approved, it would be only the third treatment allowed for COVID patients in Canada.
Colchicine is normally used by people suffering from gout, a common form of arthritis. It comes in a pill.
In treating COVID patients, colchicine works by preventing “cytokine storm,” which is when the body’s immune system attacks its own cells while trying to kill the virus, said Dr. Jean-Claude Tardif, director of the Montreal Heart Institute (MHI) and principal investigator of a recently concluded trial of the drug.
The MHI’s randomized, double-blind, placebo-controlled study showed that colchicine had positive results when given to patients suffering from COVID. ....

Jean Claude Tardif , Montreal Heart Institute , Health Canada , ஜீன் கிளாட் தாற்டிப் , மான்ட்ரியல் இதயம் நிறுவனம் , ஆரோக்கியம் கனடா ,

Researchers say effective drug 'offers hope' to help fight COVID-19


Researchers say effective drug ‘offers hope’ to help fight COVID-19
© Montreal Heart Institute
As the race to combat the coronavirus continues, researchers believe they ve found new use for an old drug, one that has been primarily used to treat gout a form of arthritis.
A study conducted by a team of researchers with the Montreal Heart Institute found that colchicine could be the first oral medication to treat non-hospitalized patients with COVID-19.
I believe that this offers a lot of hope for patients and for the governments and health-care systems, to reduce the congestion of the system and the use of intensive care units, said Dr. Jean-Claude Tardif, director of the Montreal Heart Institute research centre. ....

South Africa , United States , Jean Claude Tardif , Joe Schwarcz , Montreal Heart Institute , Montreal Heart , South America , ஒன்றுபட்டது மாநிலங்களில் , ஜீன் கிளாட் தாற்டிப் , மான்ட்ரியல் இதயம் நிறுவனம் , மான்ட்ரியல் இதயம் , தெற்கு அமெரிக்கா ,

26 January 2021 Coronavirus Charts and News: More Than One Third of COVID-19 Infections Are Asymptomatic. Moderna President Says COVID Will Be An Ongoing Battle for Next Few Years.


The U.S. new cases 7-day rolling average are 17.9 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 7.7 %
LOWER than the rolling average one week ago. U.S. deaths due to coronavirus are now 2.4 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 151,112
U.S. Coronavirus hospitalizations are at an elevated 109,936
U.S. Coronavirus deaths are at an elevated 1,915
U.S. Coronavirus immunizations have been administered to 7.1 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases worsened, hospitalizations improved, and deaths worsened ....

United States , New York , United Kingdom , South Africa , South African , Steven Hansen , Donald Trump , Anthony Fauci , Stephen Hoge , Eric Topol , Eli Lilly , Daniel Oran , Arun Gupta , Satyendar Jain , Jean Claude Tardif , Katherine Lowe , Montreal Heart Institute , Trial Steering Committee , Israeli Health Ministry , Washington Post , European Union , Oxford University , Drug Administration , Hyatt Hotels , New York Times , Delhi Medical Council ,

Common drug colchicine brings hope to Covid fight | Daily Express Online


Published on: Tuesday, January 26, 2021
By: AFP
(File pic) A pharmacist present the drug colchicine . (AFP)
MONTREAL: A major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from Covid-19, bringing “important hope” to sufferers, the lead researcher said.
Jean-Claude Tardif, head of the Montreal Heart Institute (ICM), led the study named “Colcorona,” whose preliminary results were published Friday evening.
The complete results will be made public “as quickly as possible,” he said during an interview with AFP.
ADVERTISEMENT
Q: What are the main conclusions of your study, conducted on 4,488 patients throughout the world since March 2020? ....

Jean Claude Tardif , Montreal Heart Institute , Claude Tardif , ஜீன் கிளாட் தாற்டிப் , மான்ட்ரியல் இதயம் நிறுவனம் , கிளாட் தாற்டிப் , தலைப்புச் செய்திகள் ,